Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. PBE: which is better?

Bottom line

BBH vs PBE: the short answer

BBH (VanEck Biotech ETF) and PBE (Invesco Biotechnology & Genome ETF) share a meaningful slice of their top holdings — about 40% by weight.

BBH is cheaper at 0.35% vs 0.59% — a difference of $24 a year per $10,000 invested.

Over five years, PBE returned +3.4% a year vs +2.7% for BBH.

Updated Nov 19, 2026

BBH vs PBE side by side

BBHPBE
TypeETFETF
Fund familyVanEckInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.59%
Annual cost per $10k$35$59
10-yr cost on $10k (prospectus)$443$738
Max front loadNoneNone
12b-1 fee——
1-yr return+21.2%+24.7%
5-yr return (annualized)+2.7%+3.4%
10-yr return (annualized)+4.5%+5.2%
Best quarter+27.6%+25.3%
Worst quarter−18.2%−24.3%
Net assets (fund)$395.6M$281.9M
Number of holdings2533
Portfolio turnover19%103%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHPBEDifference
2025+21.2%+24.7%−3.5%
2024−4.4%+1.1%−5.5%
2023+3.9%+3.7%+0.2%
2022−15.1%−10.8%−4.3%
2021+11.8%+1.6%+10.2%
2020+22.1%+25.5%−3.5%
2019+25.8%+18.3%+7.5%
2018−10.2%+0.2%−10.5%
2017+16.6%+22.4%−5.8%
2016−15.0%−23.0%+8.0%

Source: Fund prospectus bar charts

Holdings overlap

12 of BBH's top 25 holdings also appear in PBE's top 25.

Shared top holdings
HoldingBBHPBE
Amgen Inc15.25%5.22%
Gilead Sciences Inc12.79%4.43%
Vertex Pharmaceuticals Inc9.10%4.99%
Regeneron Pharmaceuticals Inc6.21%5.47%
Alnylam Pharmaceuticals Inc3.83%3.17%
Biogen Inc3.63%4.79%
Illumina Inc3.17%3.51%
United Therapeutics Corp2.83%4.08%
Incyte Corp2.49%3.06%
Neurocrine Biosciences Inc2.08%2.66%
Bio-Techne Corp1.54%3.73%
BioMarin Pharmaceutical Inc1.34%2.82%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FAQ

What is the difference between BBH and PBE?
BBH (VanEck Biotech ETF) and PBE (Invesco Biotechnology & Genome ETF) share a meaningful slice of their top holdings — about 40% by weight. BBH is cheaper at 0.35% vs 0.59% — a difference of $24 a year per $10,000 invested.
Which is cheaper, BBH or PBE?
BBH has the lower expense ratio (0.35%).
Should I own both BBH and PBE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.